A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)
      QxMD      Google Scholar   
Citation:
Clin Pharmacol Ther vol 105 (3) 738-45
Year:
2019
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
Yes
Biospecimen:
No
SDC:
No
Book Volume:
8
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
PPP
Sec. Committees:
Breast    
Pharmas:
Celgene, BMS  
Grants:
U10CA180821, U10CA180882, U10CA180833, U24CA19617, U10CA180836, U10CA180838, U10CA180867  
Corr. Author:
 
Authors:
                                     
Networks:
CA136, DE012, HEARTLAND, LAPS-IL036, LAPS-IL057, LAPS-MA036, SCOR   
Study
CALGB-40502
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: